SWOG clinical trial number
SWOG-8922
Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor in Advanced Soft Tissue Sarcomas
Closed
Phase
Accrual
28%
Published
Abbreviated Title
Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor in Advanced Soft Tissue Sarcomas
Activated
09/15/1990
Closed
09/15/1992
Research committees
Sarcoma
Publication Information Expand/Collapse
1996
GM-CSF did not allow doxorubicin dose escalation in the maid regimen: A phase I trial. A Southwest Oncology Group study